GLP-1 drugs work for weight loss, study finds

Compounding pharmacies make their own versions of weight loss drugs at a fraction of the price but there are some drawbacks.
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
There are currently three medications (GLP-1s) on the market that the FDA has specifically approved to treat obesity — ...